Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

St. Jude Hospital to Test Nanotech Flu Virus Drugs

Electron-microscope image of the 2009 H1N1 influenza virus (CDC.gov)

31 May 2016. A company developing anti-viral drugs delivered in nanoscale particles is partnering with scientists at St. Jude Children’s Research Hospital to test drug candidates to treat influenza. Financial details of the agreement between NanoViricides Inc. in Shelton, Connecticut and St. Jude hospital in . . . → Read More: St. Jude Hospital to Test Nanotech Flu Virus Drugs

Boehringer, Inventiva Partner on Progressive Lung Disease

High-resolution CT scan of lungs with idiopathic pulmonary fibrosis (IPF Editor, Wikimedia Commons)

31 May 2016. Drug maker Boehringer Ingelheim and biopharmaceutical company Inventiva are collaborating on discovery of new treatments for idiopathic pulmonary fibrosis and related diseases causing fibrosis. The deal is expected to bring Inventiva, in Daix, France, as much as €170 . . . → Read More: Boehringer, Inventiva Partner on Progressive Lung Disease

Memorial Day, 2016

Graves at Arlington Memorial Cemetery (A. Kotok)

30 May 2016. Today is Memorial Day in the U.S., so Science & Enterprise is taking the day off. We’ll resume our regular posting tomorrow.

* * *

Please share Science & Enterprise …

Another Chance to Get Serious on Drug Pricing

Stephen Ubl at National Press Club, 25 May 2016 (A. Kotok)

Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America, or PhRMA, told a press and industry event in Washington, D.C. on Wednesday (25 May) that drug makers are eager to develop more individualized treatments for patients, but proposed regulations on . . . → Read More: Another Chance to Get Serious on Drug Pricing

Pricing Factors Proposed for Gene Therapies

(NIH.gov)

Updated 27 May 2016. See Another Chance to Get Serious on Drug Pricing.

A pediatric cancer specialist and venture capital executive argue for establishing a framework for pricing gene therapies to treat inherited and other diseases, before these treatments are approved by FDA. Stuart Orkin, a pediatric oncologist and hematologist at Dana-Farber Cancer . . . → Read More: Pricing Factors Proposed for Gene Therapies

Self-Driving Truck Software Based on Biological Model

Ola Benderius monitors a Volvo self-driving truck on a test track in Sweden. (Henrik Sandsjö, Chalmers University of Technology)

26 May 2016. Researchers from Sweden are developing software for controlling self-driving trucks, using the way animals react and adapt to their environment as a model. The team from Chalmers University of Technology in Gothenburg . . . → Read More: Self-Driving Truck Software Based on Biological Model

Start-Up, Univ. Lab Partner on Computational Drug Discovery

(DARPA, Wikimedia Commons)

25 May 2016. A two-year old company developing algorithms for drug discovery is collaborating with University of Chicago medical school to identify candidates to prevent atherosclerosis, or hardening of the arteries. Financial aspects of the agreement between twoXAR Inc. in Palo Alto, California and the lab of Yun Fang at University . . . → Read More: Start-Up, Univ. Lab Partner on Computational Drug Discovery

Say Hello to HelloToken

(Eviatar Bach, Wikimedia Commons)

25 May 2016. Science & Enterprise, as regular visitors know, is a business and science news blog that tries to make the visiting experience both professional and productive. We’re also a business enterprise, and need to generate income to support our work. We’re starting a feature on Science & Enterprise . . . → Read More: Say Hello to HelloToken

Patent Awarded for Skin Stem Cell Regeneration Methods

Human fibroblasts undergoing cell division (Worcester Polytechnic Institute)

24 May 2016. Two faculty members at Worcester Polytechnic Institute in Massachusetts received a patent for techniques that make regeneration of human tissue with adult stem cells more direct and productive. Patent number 9,290,740 was issued by the U.S. Patent and Trademark Office in March 2016 . . . → Read More: Patent Awarded for Skin Stem Cell Regeneration Methods

Sensor Patch Tracks Chemical, Physical Vital Signs

Chem-Phys patch demonstrated by co-author Amay Bandodkar (University of California, San Diego)

24 May 2016. Engineers at University of California in San Diego developed a patch device worn on the skin with sensors that measure chemical indicators as well as physical vital signs. The UC-San Diego team that designed the device published its findings . . . → Read More: Sensor Patch Tracks Chemical, Physical Vital Signs